恆偉集團(08219.HK)組合營經營非同質化代幣區塊鏈平台
恆偉集團(08219.HK)公布,全資附屬佳賜與陳啟鋒旗下OES、曾翠華、廖靜雯、林祖舜訂立合營協議,透過股份認購事項方式成立合營公司。
佳賜旗下的恆偉實業發展(合營公司)未來名稱將變更為「優樂科技」,透過股份認購,佳賜的持股將由100%降至60%,曾翠華持股13%,林祖舜及OES各持股10%,廖靜雯持股7%。合營公司已發行股本將增至100萬元,集團初步出資總額估計將為59.99萬元,將透過集團的內部資源撥付。
集團表示,合營公司將從事開發及經營一個非同質化代幣(NFT)區塊鏈平台,以供集團發佈及銷售其手錶設計;香港本地設計師提供一個發佈及銷售NFT區塊鏈平台;於NFT區塊鏈平台發佈及銷售香港文化創意作品;及向與上述去中心化融資服務有關的交易提供技術支援。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.